These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3142217)

  • 1. Generation and characterization of cytotoxic activity against tumor cell lines in human peripheral blood mononuclear cells stimulated "in vitro" by a glucomannan-protein preparation of Candida albicans.
    Ausiello CM; Spagnoli GC; Antonelli G; Malavasi F; Dianzani F; Casciani CU; Cassone A
    J Biol Regul Homeost Agents; 1987; 1(2):59-68. PubMed ID: 3142217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin 2-activated killer cells.
    Ausiello CM; Palma C; Spagnoli GC; Piazza A; Casciani CU; Cassone A
    Cell Immunol; 1989 Jul; 121(2):349-59. PubMed ID: 2661020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of LAK-like cells in the peritoneal cavity of mice by inactivated Candida albicans.
    Scaringi L; Cornacchione P; Rosati E; Boccanera M; Cassone A; Bistoni F; Marconi P
    Cell Immunol; 1990 Sep; 129(2):271-87. PubMed ID: 2166624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro.
    Gülay Z; Imir T
    Immunobiology; 1996 Jul; 195(2):220-30. PubMed ID: 8877398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
    J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.
    Torosantucci A; Palma C; Boccanera M; Ausiello CM; Spagnoli GC; Cassone A
    J Gen Microbiol; 1990 Nov; 136(11):2155-63. PubMed ID: 1706757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma].
    Tsunoda T; Tanimura H; Yamaue H; Tani M; Iwahashi M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1110-8. PubMed ID: 2118938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
    Sarzotti M; Klimpel GR; Baron S
    Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity in glioma-bearing patients: differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen.
    Ausiello C; Maleci A; Spagnoli GC; Antonelli G; Cassone A
    J Neurooncol; 1988 Dec; 6(4):329-38. PubMed ID: 3146618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans.
    Yasukawa M; Nakagomi O; Kobayashi Y
    Clin Exp Immunol; 1990 Apr; 80(1):49-55. PubMed ID: 2157566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell wall components of Candida albicans as immunomodulators: induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions.
    Scaringi L; Marconi P; Boccanera M; Tissi L; Bistoni F; Cassone A
    J Gen Microbiol; 1988 May; 134(5):1265-74. PubMed ID: 3058863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS; Gregory SA; Edgington TS
    J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Noguchi K; Arii K; Hotta T
    Nihon Geka Hokan; 1991 Nov; 60(6):396-405. PubMed ID: 1820012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.